Article metrics

Download PDFPDF

Extended report
Efficacy and safety of tabalumab, an anti-BAFF monoclonal antibody, in patients with moderate-to-severe rheumatoid arthritis and inadequate response to TNF inhibitors: results of a randomised, double-blind, placebo-controlled, phase 3 study

 

Online download statistics by month:

Online download statistics by month: August 2015 to April 2024

AbstractFullPdf
Aug 2015522869
Sep 2015342412
Oct 201525114
Nov 2015751819
Dec 2015521212
Jan 2016621514
Feb 20164759
Mar 20162178
Apr 201646118
May 20164384
Jun 2016542210
Jul 20163675
Aug 201639157
Sep 201661716
Oct 20162186
Nov 20161664
Dec 201611635
Jan 2017402
Feb 2017134
Mar 2017085
Apr 201705226
May 20170174
Jun 201717244
Jul 201722223
Aug 201746472
Sep 201745443
Oct 201732323
Nov 201728285
Dec 201712120
Jan 201828283
Feb 201829277
Mar 201824241
Apr 201838409
May 201826285
Jun 201830306
Jul 201827270
Aug 201835354
Sep 201825256
Oct 201863619
Nov 201837332
Dec 201831317
Jan 201920204
Feb 201924236
Mar 201926256
Apr 201919196
May 201918187
Jun 201917174
Jul 201943437
Aug 201911102
Sep 201913137
Oct 2019191810
Nov 201914145
Dec 2019994
Jan 202017172
Feb 202013124
Mar 202046443
Apr 20201595
May 202014148
Jun 202017155
Jul 202011111
Aug 202011118
Sep 202039338
Oct 202048469
Nov 202029266
Dec 202019175
Jan 202123215
Feb 202115156
Mar 202116165
Apr 202117175
May 202111116
Jun 202114149
Jul 2021181811
Aug 2021151511
Sep 202112125
Oct 2021191921
Nov 20218714
Dec 202114142
Jan 202211113
Feb 202216132
Mar 202212116
Apr 2022121210
May 202231308
Jun 202226243
Jul 202219172
Aug 202228284
Sep 2022222210
Oct 2022272715
Nov 202224243
Dec 202216162
Jan 2023226913
Feb 2023992
Mar 202336365
Apr 202327238
May 2023111110
Jun 202315151
Jul 2023171710
Aug 202310107
Sep 202312120
Oct 202326246
Nov 202328249
Dec 202325225
Jan 2024161610
Feb 2024272410
Mar 2024373210
Apr 202440387
Total25912225745